Health Conditions Linked to NAD+ Decline

Reading Time: 5 min 26 sec

NAD+ is an essential molecule that plays a central role in maintaining cellular health.

It is needed for critical processes in the body, including energy metabolism, DNA repair, and the cell’s response to stress.

NAD+ levels are dynamic, with its overall concentration determined by the balance between its synthesis and breakdown.

Many diseases and biological stressors disrupt NAD+ metabolism and are associated with low levels of NAD+, such as obesity, infection, alcohol consumption, and high blood pressure.

“In 2019, 53.8% of adults aged 18─34 years had at least one chronic condition, and 22.3% had more than one condition.” (1)

Recent research suggests that replenishing NAD+ stores may be a promising therapeutic strategy for these conditions.



Key Points

  • NAD+ levels decreased by 44% in patients with high blood pressure
  • NR increased NAD+ levels 2-6 fold in young patients with Ataxia Telangiectasia
  • Low NAD+ and high CD38 levels are found in several autoimmune diseases
  • Alcohol consumption has been linked to low NAD+ levels in the CSF and liver
  • Niacin replenished NAD+ levels in patients with a muscle disease
  • Overconsumption of fat reduced muscle NAD+ levels in men
  • Viral infections reduced muscle NAD+ levels in a study
  • Restoring NAD+ levels in Acute Kidney Injury may be beneficial

High Blood Pressure

A clinical trial found that low NAD+ levels in the blood were associated with high blood pressure in adults.

“NAD+ levels were significantly decreased by 44% in PBMCs isolated from hypertensive patients.”

In these subjects, supplementation with NMN in combination with lifestyle modifications for 6 weeks led to greater improvements in blood pressure than participants that only made lifestyle modifications.

Autoimmune Diseases

Gouty arthritis: Analysis of whole blood samples showed Gouty Arthritis patients had significantly lower NAD+ levels and higher levels of the NAD+ consuming enzyme, CD38, compared to healthy controls.

Systemic Lupus Erythematosus (SLE): A study found that SLE patients that were prone to infection had significantly increased levels of the NAD+-consuming enzyme, CD38, and decreased levels of NAD+ in their white blood cells compared to healthy subjects.

Psoriasis: Serum NAD+ levels were found to be significantly lower in study with psoriatic patients when compared to the control group.

Inflammatory Bowel Disease (IBD): Dysregulation of NAD+ metabolism in IBD was reported in a study, with Intestinal tissue biopsies of IBD patients showing changes in 10 proteins involved in NAD metabolism, including the NAD+-consuming enzyme CD38, compared to healthy controls.

Neurological Function

Ataxia Telangiectasia (AT) is a genetic neurodegenerative disease. Animal studies have shown it involves persistent DNA damage, mitochondrial dysfunction, and low NAD+ levels.

A study investigated the effects of NR supplementation in AT patients over two years. The mean age of the AT patients was 13Y 2M and the average blood NAD+ levels were 13.4 μM at baseline. NR supplementation increased blood levels 2-6 fold and the patients showed improved motor coordination and eye movements.

Muscle Function

Mitochondrial Myopathy: A clinical trial showed that NAD+ levels in the blood and muscles of patients with a muscle disease were much lower than healthy individuals. Supplementation with Niacin had significant effects:

  • Blood NAD+ levels increased by 7.1-fold (4 months) and 8.2-fold (10 months)
  • Muscle NAD+ levels increased by 1.3-fold (4 months) and 2.3-fold (10 months)

Muscular Dystrophy: A study found that muscle samples from people with neuromuscular diseases had higher levels of genes that divert NAD+ precursors away from NAD+ production and lower levels of genes that help make NAD+, compared to healthy muscle samples.

  • The researchers also used a mouse model of muscular dystrophy and found that supplementation with NR replenished NAD+ levels and improved muscle function.

Alcohol Consumption

A study found that the levels of NADH in the cerebral spinal fluid (CSF) of individuals who consumed more than one drink of alcohol a day were significantly lower than individuals who did not drink.

An analysis of liver samples from patients with Alcoholic Liver Disease receiving a liver transplant showed significantly lower levels of NAD+ and the NAD+ precursors, nicotinic acid and nicotinamide riboside, compared to healthy liver samples.

In a study using a chronic ethanol mouse model, the injection of NMN (500 mg/kg) every other day for 6 weeks increased liver NAD+ levels, protected 25% of the genes modulated by ethanol, and prevented the rise in plasma markers of liver damage.

High Fat Diet

A clinical trial evaluated the effects of overconsuming fats on metabolism in the skeletal muscle of men. After 56 days on a high fat diet, muscle biopsies showed a significant reduction in NAD+ levels compared to baseline.

Infectious Diseases

Analysis of the skeletal muscle tissue of middle-aged asymptomatic people living with HIV (PLWH) showed significantly reduced levels of total NAD, NAD+, and NADH. Even lower levels were seen in those coinfected with Hepatitis C Virus or Cytomegalovirus.

The infections were also associated with increased inflammation and physiologic frailty.

Kidney Disease

Researchers conducted a series of studies using cardiac surgery cohorts, an ICU cohort, and a healthy volunteer cohort to evaluate metabolic changes in Acute Kidney Injury (AKI). They found NAD metabolism was disrupted in AKI and that increasing NAD+ levels may be a potential therapeutic strategy.

“The results propose that de novo NAD+ biosynthesis becomes impaired during human AKI and that augmentation of NAD+ metabolism may be safe and potentially beneficial.”

Another trial found supplementation with Nicotinamide Riboside and Pterostilbene (NRPT) NRPT was safe and increased whole blood NAD+ levels in hospitalized AKI patients.

Dr. Rebecca Crews profile picture

Dr. Rebecca Crews

Learn More

Leading the company’s engagement in transformative research. She is committed to scientific integrity in the health and wellness space and data transparency with consumers.

She holds a Ph.D. in Biochemical and Molecular Nutrition from Tufts University and has over ten years of nutrition science research experience, exploring various dimensions of human well-being in academic and government laboratories.